A multicenter, randomized, double-blind, placebo-controlled, intraindividual-comparison phase IIa trial to evaluate the efficacy and safety of 2% AVT-02 UE ointment in an every other day treatment of mild to moderate psoriasis vulgaris.
Phase of Trial: Phase II
Latest Information Update: 08 Sep 2012
At a glance
- Drugs AVT 02 (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 14 Jul 2011 New trial record